NCT01706510View on ClinicalTrials.gov

Antiplatelet Effects of Ticagrelor Versus Clopidogrel in American Indian Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

April 30, 2014

Conditions
Coronary Artery Disease
Interventions
DRUG

Ticagrelor

Ticagrelor 180 mg loading dose followed by 90 mg bid for 7 days ± 2 days

DRUG

Clopidogrel

Clopidogrel 600 mg loading dose followed by 75 mg Daily for 7 days ± 2 days

Trial Locations (1)

57701

Regional Heart Doctors/Black Hills Cardiovascular Research, Rapid City

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Rapid City Regional Hospital, Inc

OTHER